Background: This study was conducted to investigate the associations between polymorphisms of genes involved in LKB1 pathway and the prognosis of patients with non-small cell lung cancer (NSCLC) after surgical resection. Method: Twenty-three single nucleotide polymorphisms (SNPs) in LKB1 pathway were investigated in a total of 782 patients with NSCLC who underwent curative surgery. The association of the SNPs with overall survival (OS) and disease free survival (DFS) were analyzed. Results: Among the 23 SNPs investigated, TSC2 rs30259G>A was significantly associated with survival outcomes in multivariate analyses. The TSC2 rs30259G>A was associated with significantly worse OS and DFS (adjusted hazard ratio [aHR] ¼ 1.88, 95% confidence interval [CI] ¼ 1.21-2.91, P ¼ 0.005; aHR ¼ 1.65, 95% CI ¼ 1.15-2.38, P ¼ 0.01, under codominant model, respectively). When stratified by tumor histology, the SNP (rs30259) was significantly associated with survival outcomes only in squamous cell carcinoma, but not in adenocarcinoma. Conclusion: This study suggests that genetic variation in LKB1 pathway may be useful for the prediction of prognosis in patients with early stage NSCLC after curative surgery.

